Since a basal level of cell division is an essential pre-condition for progressive events leading to the eventual development of resistance of breast tumors to hormonal adjuvant therapy, understanding the mechanism of the hormone-independent effects of ER in hormone-sensitive cells is important. Here, ESR1 is linked to breast neoplasm.